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This is a new case of Merkel cell carcinoma of the vulva. It is a rare neuroendocrine carcinoma with an aggressive behavior.
Because of its rarity in this location, it is not clear whether it behaves diﬀerently from the usual neuroendocrine carcinomas of
the skin. A case of a 63-year-old patient with vulvar Merkel carcinoma is presented. The clinical presentation, microscopic and
immunohistochemicalfeatures, and treatment are discussed.
1.Introduction
The Merkel cell was ﬁrst described by the German histopa-
thologist Merkel in 1875 [1]. Merkel cells are components of
the basal layer of the epidermis and the follicular epithelium.
They form clusters in areas of sensory perception, close
to primary nerve endings [2]. Primary neuroendocrine
(Merkel) carcinoma of the skin was ﬁrst described by Toker
in 1972 [3]. It has an epidermal origin [4]. Vulvar Merkel
cell carcinoma is a very rare entity with aggressive behavior.
2.Case
A 63-year-old woman presented with a tumor of the left
labium of the vulva. The patient claimed pruritus treated
with corticosteroid cream the last 6 months. The biopsy
revealed a Merkel cell carcinoma of the vulva. The tumor
was stained with endocrine markers and cytokeratins 7 and
20. The cytokeratin20 staining had a perinuclear dot pattern
characteristic for Merkel cell carcinoma. It was chromo-
granin A, synaptophysin, CK18, CD56, and somatostatin
positive. It had high mitotic index (90–100κ.o.π)a n dl a r g e
number of apoptotic cells. The C/T scan showed left regional
(inguinal) node metastasis. The tumor was 9cm and lied
from the urethra up to the perineum and deep to the
periosteum of the pubic symphysis. Inguinal lymph node
metastasis (5cm) was present at the time of the surgery.
She was treated with radical vulvectomy. Radiation therapy
followed tothepelvis, perineum, vulva,andinguinal regions.
3.Discussion
Merkel cell carcinoma aﬀects elderly Caucasians (97%) with
fair skin [5, 6]. Etiologic role plays the UV radiation [4]. It
should be mentioned that viral etiology is also implicated
in the pathogenesis as the recently discovered Merkel cell
polyoma virus was found to infect the lymphoid system
[7–9]. The median age is 69–75 years [5, 6]. It is most
commonly found on sun-exposed areas such as the head
or the neck (50–60%) [10] and the extremities, but it may
also occur in the trunk or the genitalia. Tumor locations
are buttocks(43%),extremities (36%),head (7%),unknown
(14%) [11]. Because of its rarity, it is not known whether
this neoplasm behaves diﬀerently in the vulvar location
from at other sites [12]. Less than twenty cases of vulvar
Merkel carcinomas are reported [12–14]. Furthermore, a few
cases of Merkel cell carcinoma of the Bartholin’s gland are
reported in the bibliography [15]. Histologically, the tumor
is characterised by intradermal small cells with high mitotic
index and frequent apoptosis. The immunohistochemistry
is positive for cytokeratins, epithelial membrane antigen,
neuroﬁlaments, neuron-speciﬁc enolase, and chromogranin
A. Electron microscopy could reveal intermediate ﬁlaments
in a typical globular paranuclear arrangement [16]. Merkel2 Case Reports in Medicine
cells are usually identiﬁed by cytokeratin 20 stains [17].
Staging evaluation includes C/T and recently PET scan [18].
At postmortem examination, it was found that pelvic lymph
nodes, liver, and vertebral metastases are possible metastases
of vulvar Merkel cell carcinoma [19]. The diagnosis is fre-
quentlydelayed [20]. It usually presents with regional lymph
node metastases [5]. The treatment guidelines include local
excision of the primary tumor with adjuvant radiotherapy
[5]. A 3cm excision margin is advocated, including fascia
wherever possible [6]. Recent data show that treatment with
surgical excision and adjuvant locoregional radiotherapy
experiences a better disease-free interval than surgery alone
[10]. Moreover, the role of adjuvant chemotherapy is still
controversial; regimens for small cell carcinoma of the
lung are also used. The combination of cyclophosphamide,
doxorubicin, and vincristine has an overall response rate of
75%versus60%ofthecisplatinorcarboplatinplusetoposide
scheme [18]. It usually gives early local recurrences [5].
According to Lonardo et al., recurrence occurs in 86% of
stage I and 20% of stage II tumors [11].
In the bibliography, there are limited data regarding the
aggressive behaviour and poor prognosis of the tumor with
reported survival rates ranging from 31% at three years
up to 74% at ﬁve years [21]. Merkel cell carcinoma of the
vulva seems to have a more aggressive behaviour and poorer
prognosis than at other sites [12, 22].
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